NCT04375267 2023-11-14
LuPARP
Vastra Gotaland Region
Phase 1 Unknown
Clinical Trials
10 trialsNCT04979611 2023-09-21
The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma
First Affiliated Hospital of Fujian Medical University
Phase 1 Unknown
NCT02693067 2023-02-08
A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver
Provectus Pharmaceuticals
Phase 1 Unknown
NCT00986661 2022-11-02
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Provectus Pharmaceuticals
Phase 1 Unknown
NCT03478358 2022-08-31
Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors
Peking Union Medical College Hospital
Phase 1 Unknown
NCT02637531 2022-04-04
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549
Infinity Pharmaceuticals, Inc.
Phase 1 Unknown
NCT03734913 2020-07-22
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT03404414 2018-01-19
Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT
Peking Union Medical College Hospital
Phase 1 Unknown
NCT03308682 2017-10-12
177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors
Peking Union Medical College Hospital
Phase 1 Unknown
NCT00314925 2010-02-25
Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
Neotropix
Phase 1 Unknown